Robert T. Schooley, MD

Dr Schooley is a Distinguished Professor of Medicine in the Division of Infectious Diseases and Global Public Health at the University of California San Diego. He completed medical school, an internal medicine residency at Johns Hopkins, and infectious disease fellowships at the National Institutes of Health (NIH) and Massachusetts General Hospital. He joined the faculty of Harvard Medical School in 1981. His longer-term research efforts are directed at the pathogenesis and therapy of RNA virus infections. He has been heavily involved in the development of antiviral chemotherapy directed at HIV, HCV, and the herpesgroup viruses, as well as in research, teaching, and infrastructure building efforts in sub-Saharan Africa. Following his successful treatment of a multidrug resistant A. baumannii infection in a fellow faculty member at University of California San Diego, he has become interested in the use of viruses as therapeutic agents – namely, the use of bacteriophages to treat multidrug resistant bacterial infections. He currently serves as Co-Director of University of California San Diego’s phage research center (the Center for Innovative Phage Applications and Therapeutics, IPATH).

(Updated July 18, 2024)